Alphapharm

What Alphapharm does

Alphapharm is an Australian pharmaceutical manufacturer and distributor founded in 1982 and headquartered in Sydney, operating today as the Australian arm of Viatris Inc. (NASDAQ: VTRS) following its 2014 acquisition by Mylan and subsequent integration into Viatris through the November 2020 merger of Mylan and Pfizer's Upjohn division. The company produces and distributes a broad portfolio of generic and branded medicines, with over 1,000 registered products in Australia spanning multiple therapeutic areas and approximately 450 formulations globally. Manufacturing scale is substantial at 4 billion annual doses, with Australian-made medicines accounting for roughly one in three Viatris products supplied to Australian patients. Distribution is anchored by a direct Queensland warehouse handling 900 of the registered products domestically, complemented by export channels reaching more than 40 countries.

The business operates primarily through a B2B healthcare channel model rather than direct-to-consumer, with revenue derived from pharmaceutical product sales under Australia's Pharmaceutical Benefits Scheme (PBS) pricing framework. Key customer segments include Australian doctors, pharmacists, health professional organisations, the Federal Government through PBS partnerships, and patient groups, with ~800 employees supporting operations. The go-to-market is sales-led, leveraging professional relationships and education initiatives rather than consumer marketing, with complementary engagement through LinkedIn, Instagram, YouTube, X (Twitter), the corporate newsroom, and the Viatris Connect partner portal. The value proposition centres on affordable access to high-quality medicines regardless of geography or circumstance, underpinned by the scale of local manufacturing and the breadth of the global Viatris portfolio spanning 1,400+ molecules.

Name

Alphapharm

Legal name

Viatris Inc.

Website

https://alphapharm.com.au

Company type

Public

Founded year

2020

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Alphapharm is an Australian generic and branded pharmaceutical manufacturer and distributor, operating since 1982 as part of Viatris Inc., producing 1,000+ registered products across multiple therapeutic areas and serving Australian patients, healthcare professionals, and the federal PBS programme.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Generic pharmaceuticals
• Drug manufacturing
• Pharmaceutical formulations
• Medicines distribution
• Pharmaceutical products

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of generic and branded pharmaceutical medicines across 1,000+ registered products in Australia, with 900 products delivered through direct warehouse distribution in Queensland

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Alphapharm, operating as Viatris Australia, manufactures and distributes a broad portfolio of generic and branded pharmaceutical medicines in Australia. The company offers over 1,000 registered products across multiple therapeutic areas, with 450+ formulations and 4 billion annual dose capacity, delivering 900 products directly through its Queensland warehouse and exporting to 40+ countries.

Product overview

Viatris Australia operates as a pharmaceutical company within the Viatris global network, producing and distributing a broad range of high-quality medicines. The company offers over 1,000 registered products in Australia across various therapeutic areas, with approximately 900 products delivered through their Queensland warehouse. Their global portfolio spans more than 1,400 molecules. The company emphasizes access to medicines regardless of geography or circumstance, with about one-third of medicines supplied to Australian patients being Australian-made. No specific named product brands or modules are detailed in the available source material.

Differentiator

Problem solved

Functional benefit

Products and services

• Viatris Australia Pharmaceutical Medicines Portfolio

Quantifiable outcome

• Approximately 1 in 3 Viatris medicines supplied to Australian patients are Australian made
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Doctors and Healthcare ProfessionalscoreChannel Partner/ Reseller/ DistributorPartnerships with doctors and healthcare professionals across Australia to provide access to a broad range of medicines and support education on appropriate medicine use
• Pharmacists and Pharmacy NetworkscoreChannel Partner/ Reseller/ DistributorPartnerships with pharmacists and pharmacy networks for medicine dispensing and patient education on appropriate medicine use
• Health Professional OrganisationscoreStrategic or Co-development PartnerStrategic partnerships with health professional organisations to support better health outcomes for Australians through medicine access and education
• Australian Federal GovernmentcoreChannel Partner/ Reseller/ DistributorPartnership with Federal Government for supply of affordable medicines through PBS (Pharmaceutical Benefits Scheme)
• Patient GroupscoreStrategic or Co-development PartnerPartnerships with patient groups to help bring affordable medicines to Australians and support education on appropriate use
• Business PartnersminorChannel Partner/ Reseller/ DistributorPartnerships with other business partners in Australia to help bring affordable medicines to Australians

Scale indicators7 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Sandoz (Novartis): Global leader in generic pharmaceuticals and biosimilars spun out from Novartis. Directly comparable to Alphapharm as a large-scale generic finished dosage form manufacturer serving global markets including Australia with similar product breadth and PBS participation.
• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with extensive portfolio of finished dosage forms across all therapeutic areas. Operates in Australia and competes head-to-head with Alphapharm in PBS generic categories.
• Apotex: Canadian-headquartered generic pharmaceutical manufacturer with significant global operations including Australia. Competes directly with Alphapharm in generic finished dosage forms across multiple therapeutic categories.
• Mayne Pharma: Australian-headquartered specialty and generic pharmaceutical company with manufacturing operations in Australia. Directly comparable as a domestic Australian generic manufacturer serving PBS with overlapping therapeutic areas.
• Aurobindo Pharma: India-headquartered global generic pharmaceutical manufacturer with significant Australian presence and PBS registrations. Competes with Alphapharm on price and scale across generic categories supplied to the Australian market.
• Dr. Reddy's Laboratories: India-based global generic pharmaceutical manufacturer with Australian operations and PBS-listed products. Directly comparable as a large-scale generic finished dosage form manufacturer targeting Australia.
• Lupin Pharmaceuticals: India-headquartered global generic pharmaceutical manufacturer with Australian commercial presence. Comparable as a competitor in generic finished dosage forms across therapeutic categories including those supplied under PBS.
• Arrotex Pharmaceuticals: Australia's largest generic pharmaceutical company, formed through mergers of several Australian generics businesses. Direct head-to-head competitor to Alphapharm in PBS generic categories with comparable scale and therapeutic area coverage.

Regional players

• Aspen Pharmacare: South African-headquartered multinational pharmaceutical company with presence in Australia and other markets. Operates as a generic and specialty manufacturer serving similar healthcare markets to Alphapharm, though primarily focused on African and other geographies.
• Sigma Healthcare: Australian pharmaceutical wholesale and distribution business serving community pharmacies. Adjacent comparable as part of the Australian pharmaceutical supply chain, though primarily a distributor rather than manufacturer like Alphapharm.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/alphapharmcaree
• YouTubeyoutube.com/viatris
• LinkedInlinkedin.com/company/alphapharm
• Instagraminstagram.com/viatrisinc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alphapharm